Jyoti Palaniappan, SVP, Diagnostics, immuno SEQ Dx at Adaptive Biotechnologies Corp (ADPT), sold 32,104 shares at $45.32 ($1.4M) on 2021-03-18, disclosed to the SEC on 2021-03-19.
Open-market sale of $1.4M ADPT by SVP, Diagnostics, immuno SEQ Dx. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.04 | 8,342 | $359K | 25.7% |
| 2 | $43.04 | 8,342 | $359K | 25.7% |
| 3 | $43.83 | 5,971 | $262K | 18.7% |
| 4 | $43.83 | 5,971 | $262K | 18.7% |
| 5 | $45.32 | 1,739 | $79K | 5.6% |
| 6 | $45.32 | 1,739 |
| $79K |
| 5.6% |
| Total | $43.58 avg | 32,104 | $1.4M | 100% |
| Filing → |
| ADPT | SELL | 2021-05-19 | $23K | — | Filing → |
| ADPT | SELL | 2021-04-21 | $107K | — | Filing → |